| 1 |
[GO] |
2024―Dez―04 |
Study of TNF-α, IFN-γ, IL-10, TGF-β and IL-6 Gene Polymorphisms in a Cohort of Professionals Who Worked in the First Pandemic Wave in the Brazilian Amazon |
Beatriz dos Reis Marcelino, Marcelo Cleyton da Silva Vieira, Marcos Jessé Abrahão Silva, Lilian Cristina Santos Sinfronio da Silva, Ellen Polyana da Costa Gurrão, Everaldina Cordeiro dos Santos, et al. (+7) Jeanne Gonçalves Cabral, Alex Brito Souza, Daniele Melo Sardinha, Rebecca Lobato Marinho, Sebastião Kauã de Sousa Bispo, Karla Valéria Batista Lima, Luana Nepomuceno Gondim Costa Lima |
| 2 |
[GO] |
2023―Sep―27 |
Plausible influence of HLA class I and class II diversity on SARS-CoV-2 vulnerability |
Neha Sharma, Gaurav Sharma, Devinder Toor |
| 3 |
[GO] |
2021―Sep―30 |
Dysregulated innate immune and inflammatory responses in SARS-CoV-2 infection and COVID-19 severity |
kesavardana sannula, Poulami Ghosh, Sahana Nagaraja, Sharath Basavaraju |
| 4 |
[GO] |
2021―Sep―28 |
Severe cases in COVID-19 and high association with causes of immune dysregulation : A systematic Review |
Alex Torres, Silvana Marchioro, Marcos Ribeiro, Isa Morais, Songeli Freire, Roberto Meyer |
| 5 |
[GO] |
2020―Dez―02 |
Preface for Special Issue on COVID-19 |
Geraldo Passos |
| 6 |
[GO] |
2020―Nov―03 |
COVID-19 pandemics and dysbiosis: can the ivermectin hysteria lead to an increase of autoimmune neuroinflammatory diseases? |
Jean Pierre Schatzmann Peron, Helder Nakaya, Marco Antônio Machado Schlindwein, Marcus Vinicius Magno Gonçalves |
| 7 |
[GO] |
2020―Okt―20 |
COVID-19 and Strategies for Its Therapeutics |
Fayang Ma, Tingxuan Gu, Simin Zhao, Kangdong Liu, Zigang Dong |
| 8 |
[GO] |
2020―Okt―15 |
Immunological Biomarkers of COVID-19 |
Rongwei Lei, Chandra Mohan |
| 9 |
[GO] |
2020―Okt―07 |
Molecular Insights Into SARS-CoV-2 Pathobiology: Dissecting the Interplay Between Cellular-Innate Immunity and Immune Evasion |
Prakasha Kempaiah, Dawid Maciorowski, Sara Mohama, Mohammed A Alsawi, David J Ilc, Yash Gupta, et al. (+2) Samir El Idrissi, James P Lodolce |
| 10 |
[GO] |
2020―Sep―30 |
Neutrophils and COVID-19: what is going on? |
Cleni Mara Marzocchi Machado, Micássio Fernandes de Andrade |
| 11 |
[GO] |
2020―Sep―18 |
In COVID-19 vaccines, size of viral proteins <70 kDa prevents developing of long-lasting B cell immune memory and IgG2a production |
Javier Martín Oncina |
| 12 |
[GO] |
2020―Sep―18 |
Immunology of transplant patients with SARS-CoV-2 Infection: Transmission, Immune Response, and Therapeutic Strategy |
Meixi Wang, Yuanyuan Zhao, Lai Wei, Dong Chen, Bo Yang, Zhishui Chen |
| 13 |
[GO] |
2020―Jun―10 |
MAIT Cells in COVID-19: Heroes, Villains, or Both? |
Mansour Haeryfar |
| 14 |
[GO] |
2020―Jun―03 |
Novel Coronavirus SARS-CoV-2 Target and Disable Natural Killer Cells, the Core Immune Effectors Important in Fighting the Disease |
Anahid Jewett |
| 15 |
[GO] |
2020―Mai―29 |
Immune Computation and COVID-19 Mortality: A Rationale for IVIg |
Irun Cohen, Sol Efroni, Henri Atlan |
